Impact of tumour necrosis factor-α polymorphisms on irritant contact dermatitis

Contact Dermatitis

Volumn 66, Issue 4, 2012, Pages 221-227

  Landeck, Lilla ^a   Visser, Maaike ^b   Kezic, Sanja ^b   John, Swen M ^a  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Contact dermatitis; Cytokines; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HIGH RISK PATIENT; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IRRITANT DERMATITIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL SKIN DISEASE; PREVALENCE; STUDENT;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DERMATITIS, IRRITANT; DERMATITIS, OCCUPATIONAL; GENOTYPE; HAND DERMATOSES; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84857985251     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2011.02045.x     Document Type: Article

References (37)

1. Veien N K, Hattel T, Laurberg G. Hand eczema: causes, course, and prognosis I. Contact Dermatitis 2008: 58: 330-334. (Pubitemid 351733068)
2. Thyssen J P, Johansen J D, Linneberg A, Menné T. The epidemiology of hand eczema in the general population - prevalence and main findings. Contact Dermatitis 2010: 62: 75-87.
3. Cahill J, Keegel T, Nixon R. The prognosis of occupational contact dermatitis in 2004. Contact Dermatitis 2004: 51: 219-226. (Pubitemid 40037044)
4. Coenraads P J. Hand eczema is common and multifactorial. J Invest Dermatol 2007: 127: 1568-1570.
5. Allen M H, Wakelin S H, Holloway D, Lisby S, Baadsgaard O, Barker J N, McFadden J P. Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 2000: 51: 201-215.
6. Davis J A, Visscher M O, Wickett R R, Hoath S B. Influence of tumour necrosis factor-α polymorphism-308 and atopy on irritant contact dermatitis in healthcare workers. Contact Dermatitis 2010: 63: 320-332.
7. de Jongh C M, John S M, Bruynzeel D P et al. Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis 2008: 58: 269-277. (Pubitemid 351537623)
8. Diepgen T L, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996: 49: 1031-1038. (Pubitemid 26319038)
9. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelfrequencies.net. Tissue Antigens 2003: 61: 403-407.
10. Piguet P F, Grau G E, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991: 173: 673-679.
11. Groves R W, Allen M H, Ross E L, Barker J N, MacDonald D M. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995: 132: 345-352.
12. Kimber I, Cumberbatch M, Dearman R J, Bhushan M, Griffiths C E. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 2000: 142: 401-412. (Pubitemid 30159060)
13. Hoefakker S, Caubo M, van 't Erve E H, Roggeveen M J, Boersma W J, van Joost T, Notten W R, Claassen E. In vivo cytokine profiles in allergic and irritant contact dermatitis. Contact Dermatitis 1995: 33: 258-266.
14. Corsini E, Galli C L. Cytokines and irritant contact dermatitis. Toxicol Lett 1998: 102-103: 277-282. (Pubitemid 29021233)
15. McKenzie R C, Sauder D N. The role of keratinocyte cytokines in inflammation and immunity. J Invest Dermatol 1990: 95: 105S-107S.
16. Kaijzel E L, van Krugten M V, Brinkman B M et al. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998: 4: 724-733. (Pubitemid 29051378)
17. Howell WM, Turner S J, Collins A, Bateman A C, Theaker J M. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur J Immunogenet 2002: 29: 17-23. (Pubitemid 34146655)
18. Tolusso B, Fabris M, Caporali R et al. -238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett 2005: 96: 103-108. (Pubitemid 39600765)
19. Höhler T, Kruger A, Gerken G, Schneider P M, Meyer zum Büschenefelde K H, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998: 111: 579-582.
20. Höhler T, Kruger A, Gerken G, Schneider P M, Meyer zum Büschenfelde K H, Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. JMed Virol 1998: 54: 173-177.
21. Long F, Sun C, Deng D, Zhou X, Li X P, Zhang Y P. TNF-238A is associated with juvenile onset psoriasis in patients of Han population in Southwest China. J Dermatol Sci 2004: 36: 109-111. (Pubitemid 39424135)
22. Höhler T, Kruger A, Schneider P M, Schopf R E, Knop J, Rittner C, Meyer zum Büschenfelde K H, Märker-Hermann E. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997: 109: 562-565.
23. Nedoszytko B, Szczerkowska-Dobosz A, Zab lotna M, Gleń J, Reba la K, Roszkiewicz J. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol 2007: 157: 165-167. (Pubitemid 46934284)
24. Reich K, Mössner R, König I R, Westphal G, Ziegler A, Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 2002: 118: 155-163. (Pubitemid 34107437)
25. Haas J P, Kimura A, Truckenbrodt H, Suschke J, Sasazuki T, Volgger A, Albert E D. Early-onset pauciarticular juvenile chronic arthritis is associated with a mutation in the Y-box of the HLA-DQA1 promoter. Tissue Antigens 1995: 45: 317-321.
26. Hajeer A H, Hutchinson I V. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 2000: 50: 216-228. (Pubitemid 30610098)
27. Daly A K, Day C P. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001: 52: 489-499.
28. López P, Gutiérrez C, Suárez A. IL-10 and TNF alpha genotypes in SLE. J Biomed Biotechnol 2010: 2010: 1-11.
29. Smith A J, Humphries S E. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009: 20: 43-59.
30. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf R E, Galle P R, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000: 114: 1180-1183. (Pubitemid 30415236)
31. Wilson A G, di Giovine F S, Blakemore A I, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992: 1: 353.
32. Wilson A G, Symons J A, McDowell T L, McDevitt HO, Duff G W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997: 94: 3195-3199. (Pubitemid 27157287)
33. Wilson A G, de Vries N, Pociot F, di Giovine F S, van der Putte L B, Duff G W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993: 177: 557-560. (Pubitemid 23117109)
34. Abraham L J, French M A, Dawkins R L. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993: 92: 14-18. (Pubitemid 23113892)
35. Fong C L, Siddiqui A H, Mark D F. Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene. Nucleic Acids Res 1994: 22: 1108-1114.
36. Huizinga TW, Westendorp R G, Bollen E L et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997: 72: 149-153. (Pubitemid 27062770)
37. Westphal G A, Schnuch A, Moessner R, König I R, Kränke B, Hallier E, Ziegler A, Reich K. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 2003: 48: 93-98. (Pubitemid 36513180)